Data Sources Definitions

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
Biostatistics Practice2. Example: A study shows that 70% of all patients coming to a certain medical clinic have to wait at least fifteen minutes to see.
ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
10 Points to Remember on Lifestyle Management to Reduce Cardiovascular RiskLifestyle Management to Reduce Cardiovascular Risk Summary Prepared by Elizabeth.
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Exercise the Medicine of Choice Reducing Cardiovascular Risk Dr. Lynn Panton Florida State University College of Human Sciences Department of Nutrition,
השמנת יתר חמד " ע פרופ ' ארדון רובינשטין.
What is Diabetes?.
Health Screening. Should you go for health screening? Health screening helps to discover if a person is suffering from a particular disease or condition,
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Presented at the XIV International Symposium on Atherosclerosis Rome, Italy June 18–22, 2006 Prevalence of Dyslipidemia Estimated from a Self-Reported.
Hyperlipidemia Chapter 22. VIDEO There are four principal lipoprotein classes:lipoprotein 1. Chylomicrons are derived from intestinal absorption of exogenous.
Note Final Exam-please check final schedule Essays due-lateness unacceptable.
Routine screening tests Hai Ho, M.D.. Most expensive part of medical practice? Your Pen.
Hyperlipidemia John Baer.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
METABOLIC Syndrome: a Global Perspective
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
Diabetes National Diabetes Control Programme
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Colorado Thyroid Disease Prevalence Study Arch.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Plasma triglycerides and type III hyperlipidemia.
PREVALENCE AND RISK FACTORS FOR NON- ALCOHOLIC FATTY LIVER DISEASE AMONG AN URBAN AGING ADULT SRI LANKAN POPULATION– RAGAMA HEALTH STUDY 7-YEAR FOLLOW.
Abstract The metabolic syndrome (MetS) has surpassed smoking as the number one cause of cardiovascular deaths in the US. However, it remains under diagnosed.
Chapter 09 9 Hyperlipidemia and Dyslipidemia C H A P T E R Grandjean, Gordon, Davis, and Durstine.
Diabetes Fact Sheet in Korea 2016.
Metabolic syndrome: Evidences from the Korean National Health and Nutrition Examination Survey Tran Binh Thang, MPH National Cancer Center Graduate School.
Note Final Exam-please check final schedule.
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Leah Li MRC Centre of Epidemiology for Child Health
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
Cardiometabolic Health for Adult Diabetics Living in Beijing China
Figure. Changes in the proportion of AD and exclusive breast-feeding in children at 1 to 3 years of age (KNHANES-IV and V, ). This survey was.
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Diabetes Health Status Report
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
Hypertension in Children and Adolescents
“Sick Fat,” Metabolic Disease, and Atherosclerosis
Amphitheater Public Schools
Diabetes Fact Sheet in Korea 2016.
“Sick Fat,” Metabolic Disease, and Atherosclerosis
The Chemical Differences Between EPA and DHA.
Note Final Exam-please check final schedule.
A: Epidemiology update
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Type 2 diabetes: Overlap of clinical conditions
Cardiovascular disease: Leading cause of death
Note Final Exam-please check final schedule
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
List of figure titles Estimated percentage of people aged 20 years or older with diagnosed and undiagnosed diabetes, by age group, United States, 2005–2008.
Note Final Exam-please check final schedule.
Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition.
Note Final Exam-please check final schedule.
The complications of obesity according to the values of BMI and waist circumference in an obese population of Tangier Nadia HAMJANE 1, Fatiha BENYAHYA1,2,
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Section II: Lipid management
II PAHO-DOTA Workshop on Quality of Care of Diabetes Care
Prepared by :Dr. Latifa Mari’e
Presentation transcript:

Data Sources Definitions The estimates in this fact sheet were derived from data on the 2013 Korean National Health and Nutritional Examination Survey (KNHANES) conducted by the Korean Centers for Disease Control and Prevention (KCDC) and the Korean Ministry of Health and Welfare. The estimated percentage of people with dyslipidemia receiving lipid-lowering medication was determined from the National Health Insurance Service in Korea. Definitions The following terms were defined according to the Korean guideline for the management of dyslipidemia (3rd version) from Korean Society of Lipidology and Atherosclerosis (KSLA). Hyper-LDL-cholesterolemia LDL-cholesterol (LDL-C) ≥160 mg/dL or use of lipid-lowering medication for > 20 days/month Hypertriglyceridemia Triglycerides (TG) ≥200 mg/dL. Hypo-HDL-cholesterolemia HDL-cholesterol (HDL-C) <40 mg/dL. Dyslipidemia One or more of the definitions stated above or previous diagnosis of dyslipidemia LDL-C: Low-density lipoprotein cholesterol HDL-C: HDL: High-density lipoprotein cholesterol TG: Triglycerides

Prevalence of Dyslipidemia • Approximately half of adults aged 30 years or older had dyslipidemia. • About 6 out of every 10 men and 4 out of every 10 women were dyslipidemic.

Prevalence of Dyslipidemia by Age Group • Throughout all age groups of 30 years or older, about half of men had dyslipidemia. • On the other hand, the prevalence of dyslipidemia in women tended to substantially increase after the age of 50.

Treatment with Lipid-lowering Medication • According to the data from National Health Insurance Service in korea, percentage of people with dyslipidemia receiving lipid-lowering medication was increasing for the past 10 years. In 2013, the percentage of patients receiving lipid-lowering medication was 5 times greater compared to 2003.

Prevalences of Dyslipidemia Subtypes • About 1 out of every 6 adults aged 30 years or older had hyper-LDL-cholesterolemia, and its prevalence was greater in women than in men. • Prevalences of hypertriglyceridemia and hypo-HDL-cholesterolemia in men were about twice as great as those in women. • Among men aged 30 years or older, about 1 out of every 4 men had hypertriglyceridemia, and 1 out of every 3 men had hypo-HDL-cholesterolemia.

Hyper-LDL-cholesterolemia • The prevalence of hyper-LDL-cholesterolemia increased with age, where 1 out of every 5 men and 1 out of every 3 women aged 60 years or older had hyper-LDL-cholesterolemia. • Percentages of women with hyper-LDL-cholesterolemia in their 50s were 6 times and 3 times greater than those of women in their 30s and 40s, respectively.

Hypertriglyceridemia • Hypertriglyceridemia was more prevalent in men than in women. The prevalences of hypertriglyceridemia in their 30s, 40s and 50s were 4 times, 2.5 times and 2 times greater than those of women within the same age groups.

Obesity and Dyslipidemia • About half of overweight or obese adults had dyslipidemia. • Even within the normal range of body weight, 1 out of every 3 adults had dyslipidemia. • In cases with abdominal obesity, 2 out of every 3 adults showed dyslipidemic profiles.

Diabetes and Dyslipidemia • About 3 out of every 4 adults with diabetes had dyslipidemia. • When the LDL-C cut-off value was strictly set to 100 mg/dL, more than 90% of people with diabetes had dyslipidemia.

Hypertension and Dyslipidemia • Approximately 2 out of every 3 adults with hypertension were dyslipidemic.

Prevalence of Metabolic Syndrome • About 1 out of every 3 adults aged 30 years or order had metabolic syndrome. • Percentage of men in their 50s or younger with metabolic syndrome was 2-3 times greater than that of age-matched women. In women with the ages of 50-59, a twofold increase in the prevalence of metabolic syndrome was observed.

Hyper-LDL-cholesterolemia and Metabolic Syndrome in Postmenopausal Women • Prevalences of dyslipidemia and metabolic syndrome in postmenopausal women were 4 times greater than those of premenopausal women.

Average Lipid Profiles in Korea • The mean (average) serum total cholesterol levels in adults aged 30 years or older were 189 mg/dL in men and 192 mg/dL in women.

SUMMARY (1) DYSLIPIDEMIA FACT SHEET IN KOREA 2015 • More than 16 million (47.8%) Korean adults aged 30 years or older had dyslipidemia. About 6 out of every 10 men (57.6%) and 4 out of every 10 women (38.3%) were dyslipidemic. • Prevalence of dyslipidemia increased in an age-dependent manner, and it was more evident in women with ages of 50 and over. • Percentage of people receiving treatment with lipid-lowering medication increased by 5 times in 2013 compared to 2003. • About 1 in every 6 adults aged 30 years or older had hyper-LDL-cholesterolemia, and it was more common in women than in men. The prevalence increased in an age-dependent manner, such that about 1 in every 5 men and every 3 women aged 60 years or older had hyper-LDL-cholesterolemia. • In all age groups, prevalences of hypertriglyceridemia and hypo-HDL-cholesterolemia in men were approximately twice as great as those in women. Especially, in the age group of 30-39 years, the percentage of men with hypertriglyceridemia was 4 times greater than that of women.

SUMMARY (2) DYSLIPIDEMIA FACT SHEET IN KOREA 2015 • Dyslipidemia was seen in 1 out of every 3 adults with normal body weight and in about half of overweight or obese adults. About 2 out of every 3 adults with abdominal obesity were dyslipidemic. • About 3 out of every 4 adults with diabetes had dyslipidemia. When the LDL-C cut-off value was strictly set to 100 mg/dL, 9 out of every 10 adults with diabetes were diagnosed with dyslipidemia. • Approximately 2 out of every 3 adults with hypertension had dyslipidemia. • About 1 out of every 3 adults aged 30 years or older had metabolic syndrome. • Prevalences of hyper-LDL-cholesterolemia and metabolic syndrome in postmenopausal women were 4 times greater than those in premenopausal women.